Loola Al-Kassim
Pfizer
2 Papers
Loola Al-Kassim is an academic researcher from Pfizer. The author has contributed to research in topics: Pyruvate carboxylase & Protein engineering. The author has an hindex of 2, co-authored 2 publications. Previous affiliations of Loola Al-Kassim include Vanderbilt University.
Chat about Author
Papers
The structure of the carboxyltransferase component of acetyl-coA carboxylase reveals a zinc-binding motif unique to the bacterial enzyme.
Patrick W. Bilder,Sandra Lightle,Graeme Bainbridge,Jeffrey F. Ohren,Barry C. Finzel,Fang Sun,Susan Holley,Loola Al-Kassim,Cindy Spessard,Michael Melnick,Marcia E. Newcomer,Grover L. Waldrop +11 more
TL;DR: The structures of the bacterial CT subunits from two prevalent nosocomial pathogens, Staphylococcus aureus and Escherichia coli, are presented and both reveal a small, independent zinc-binding domain that lacks a complement in the primary sequence or structure of the eukaryotic homologue.
Rational protein engineering in action: the first crystal structure of a phenylalanine tRNA synthetase from Staphylococcus haemolyticus.
Artem G. Evdokimov,Marlene Mekel,Kim Hutchings,Lakshmi Narasimhan,Tod P. Holler,Teresa McGrath,Bryan Beattie,Eric B. Fauman,Chunhong Yan,H. Heaslet,R.L. Walter,Barry C. Finzel,Jeffrey F. Ohren,Patrick I. McConnell,Timothy Braden,Fang Sun,Cindy Spessard,Craig Banotai,Loola Al-Kassim,Weijun Ma,Paul Wengender,Denis Kole,Norman Garceau,Peter L. Toogood,Jia Liu +24 more
TL;DR: This article describes for the first time the high-resolution crystal structure of a phenylalanine tRNA synthetase from the pathogenic bacterium Staphylococcus haemolyticus and executes a rational surface mutagenesis strategy that has yielded crystals of this 2300-amino acid multidomain protein.
16